Study Summary
The primary objectives of this study are to evaluate the safety and efficacy of brexucabtagene autoleucel (KTE-X19) in pediatric and adolescent participants with relapsed/refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL) or relapsed or refractory (r/r) B-cell non-Hodgkin lymphoma (NHL). As of October 2022, no further patients with acute B-cell Acute Lymphoblastic Leukemia (ALL) will be asked to join the study. The study remains open for recruitment for patients that have B-cell Non Hodgkin Lymphoma (NHL).
Want to learn more about this trial?
Request More InfoInterventions
Brexucabtagene Autoleucel (KTE-X19)BIOLOGICAL
No description available.
FludarabineDRUG
Administered intravenously
CyclophosphamideDRUG
Administered intravenously
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Children's Hospital Los Angeles | Los Angeles | California | United States |
| Children's Hospital of Orange County | Orange | California | United States |
| UCSF Benioff Children's Hospital | San Francisco | California | United States |
| University of Miami Hospital & Clinics | Miami | Florida | United States |
| Kapi'olani Medical Center for Women and Children | Honolulu | Hawaii | United States |
| Ann & Robert H. Lurie Children's Hospital | Chicago | Illinois | United States |
| Johns Hopkins University | Baltimore | Maryland | United States |
| Children's Hospitals and Clinics of Minnesota | Minneapolis | Minnesota | United States |
| Columbia University Irving Medical Center/Morgan Stanley Children's Hospital-NYP | New York | New York | United States |
| University of Rochester Medical Center | Rochester | New York | United States |
| The Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | United States |
| Monroe-Carell Jr. Children's Hospital at Vanderbilt | Nashville | Tennessee | United States |
| Texas Children's Hospital | Houston | Texas | United States |
| The University of Texas M.D. Anderson Cancer Center | Houston | Texas | United States |
| University of Virginia Health System, Pediatric Hematology/Oncology Clinic | Charlottesville | Virginia | United States |
| University Hospital Gent | Ghent | Belgium | |
| The Hospital for Sick Children | Toronto | Canada | |
| University Hospital Brno | Brno | Czechia | |
| Unité d'Oncologie et Hématologie Pédiatriques | Bordeaux | France | |
| Institut d'Hematologie et Oncologie Pediatrique | Lyon | France | |
| Hopital d'Enfants la Timone | Marseille | France | |
| Hopital Robert Debre - Sevice d'Hemato-immunologic | Paris | France | |
| University Medical Center Hamburg-Eppendorf (UKE) | Hamburg | Germany | |
| Bambino Gesù Children's Hospital | Rome | Italy | |
| Prinses Maxima Centrum | Utrecht | Netherlands | |
| Jurasz University Hospital 1; Collegium Medicum | Bydgoszcz | Poland | |
| Wroclaw Medical University | Wroclaw | Poland | |
| Hospital Sant Joan de Déu | Barcelona | Spain | |
| Hospital Universitario La Paz | Madrid | Spain | |
| Karolinska University Hospital | Stockholm | Sweden |